Design, synthesis and anticancer activity of new monastrol analogues bearing 1,3,4-oxadiazole moiety
作者:Fatma A.F. Ragab、Sahar M. Abou-Seri、Salah A. Abdel-Aziz、Abdallah M. Alfayomy、Mohamed Aboelmagd
DOI:10.1016/j.ejmech.2017.06.026
日期:2017.9
A series of dihydropyrimidine (DHPM) derivatives bearing 1,3,4-oxadiazole moiety was designed and synthesized as monastrol analogues. The new compounds were screened for their cytotoxic activity toward 60 cancer cell lines according to NCI (USA) protocol. Seven compounds were further examined against the most sensitive cell lines, leukemia HL-60(TB) and MOLT-4. The most active compounds were 9m against
设计并合成了一系列带有1,3,4-恶二唑部分的二氢嘧啶(DHPM)衍生物,作为monastrol类似物。根据NCI(USA)方案,筛选了这些新化合物对60种癌细胞系的细胞毒活性。进一步针对最敏感的细胞系白血病HL-60(TB)和MOLT-4检测了7种化合物。活性最高的化合物对HL-60(TB)的 抗性为9m(IC 50 = 56 nM),对MOLT-4的活性为9n(IC 50 = 80 nM),比蒙那那尔更强(分别为IC 50 = 147和215 nM)。9m处理的HL-60(TB)细胞和9n处理的MOLT-4细胞的细胞周期分析 如膜联蛋白V-FITC染色所显示的,显示出在G2 / M期的细胞周期停滞和促凋亡活性。